EARNINGS (LOSS) PER SHARE (Details - Antidilutive shares) - shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total anti-dilutive common stock equivalents | 18,670,141 | 791,316,043 |
| Convertible Notes Payable [Member] | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total anti-dilutive common stock equivalents | 18,670,141 | 777,016,043 |
| Vested Shares To Directors And Officers [Member] | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total anti-dilutive common stock equivalents | 0 | 8,200,000 |
| Unvested Shares To Directors And Officers [Member] | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total anti-dilutive common stock equivalents | 0 | 6,100,000 |